Facility Volume and Changing Facilities for Postoperative Radiotherapy in Salivary Gland Cancer

Rushi Patel,Aman M. Patel,Lucy Revercomb,Vivienne Qie,Christopher C. Tseng,Soly Baredes,Richard Chan Woo Park
DOI: https://doi.org/10.1002/lary.31588
IF: 2.97
2024-06-21
The Laryngoscope
Abstract:Patients treated at high‐volume facilities (HVFs) for salivary gland cancer experience worse survival if changing facility for postoperative radiation therapy (PORT). Our results suggest that patients treated surgically at HVFs should be counseled to continue their PORT at the same institution. Objectives Changing location of postoperative radiotherapy (PORT) after treatment at a high‐volume facility (HVF) is associated with worse survival in various head and neck cancers. Our study investigates this relationship in salivary gland cancer (SGC). Methods The 2004–2016 National Cancer Database was queried for all cases of adult SGC treated with surgery and PORT with or without adjuvant chemotherapy. Patients with multiple cancer diagnoses, metastatic disease, or unknown PORT facility were excluded. Reporting facilities with >95th percentile annual case volume were classified as HVFs, the remainder were classified low‐volume facilities (LVFs). Results A total of 7885 patients met inclusion criteria, of which 418 (5.3%) were treated at an HVF. Patients treated at an HVF had higher rates clinical nodal positivity (18.2% vs. 14.0%, p
medicine, research & experimental,otorhinolaryngology
What problem does this paper attempt to address?